Miniatura

Fitxers

590548.pdf (334.29 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2007

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/22490

Validity of an adaptation of the Framingham Cardiovascular Risk Function: the VERIFICA Study.

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1136/jech.2005.038505

Resum

Background: To assess the reliability and accuracy of the Framingham coronary heart disease (CHD) risk function adapted by the Registre Gironi del Cor (REGICOR) investigators in Spain.#N##N#Methods: A 5-year follow-up study was completed in 5732 participants aged 35–74 years. The adaptation consisted of using in the function the average population risk factor prevalence and the cumulative incidence observed in Spain instead of those from Framingham in a Cox proportional hazards model. Reliability and accuracy in estimating the observed cumulative incidence were tested with the area under the curve comparison and goodness-of-fit test, respectively.#N##N#Results: The Kaplan–Meier CHD cumulative incidence during the follow-up was 4.0% in men and 1.7% in women. The original Framingham function and the REGICOR adapted estimates were 10.4% and 4.8%, and 3.6% and 2.0%, respectively. The REGICOR-adapted function’s estimate did not differ from the observed cumulated incidence (goodness of fit in men, p = 0.078, in women, p = 0.256), whereas all the original Framingham function estimates differed significantly (p<0.001). Reliabilities of the original Framingham function and of the best Cox model fit with the study data were similar in men (area under the receiver operator characteristic curve 0.68 and 0.69, respectively, p = 0.273), whereas the best Cox model fitted better in women (0.73 and 0.81, respectively, p<0.001).#N##N#Conclusion: The Framingham function adapted to local population characteristics accurately and reliably predicted the 5-year CHD risk for patients aged 35–74 years, in contrast with the original function, which consistently overestimated the actual risk.

Matèries

Avaluació del risc per la salut, Malalties cardiovasculars, Cribratge, Medicina preventiva

Matèries (anglès)

Health risk assessment, Cardiovascular diseases, Medical screening, Preventive medicine

Citació

Col·leccions

Articles publicats en revistes (Medicina)

Citació

MARRUGAT, Jaume, SUBIRANA CACHINERO, Isaac, COMÍN, Eva, CABEZAS, Carmen, VILA, Joan, ELOSUA, Roberto, NAM, Byung-ho, RAMOS, Rafel, SALA MONTERO, Joan, SOLANAS SAURA, Pascual, CORDÓN GRANADOS, Ferran, GENÉ BADIA, Joan, D'AGOSTINO, Ralph b.. Validity of an adaptation of the Framingham Cardiovascular Risk Function: the VERIFICA Study.. _Journal of Epidemiology and Community Health_. 2007. Vol. 61, núm. 1, pàgs. 40-47. [consulta: 23 de gener de 2026]. ISSN: 0143-005X. [Disponible a: https://hdl.handle.net/2445/22490]

Exportar metadades

JSON - METS

Compartir registre